Ruiz Briseno Andres sold $382K of IDYA
Ruiz Briseno Andres (Chief Accounting Officer) sold 9,550 shares of IDEAYA Biosciences, Inc. (IDYA) at $40.01 ($0.38M total) on 2026-07-07 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale size, price, and post-transaction holdings by the CFO under a pre-arranged 10b5-1 plan.
Market read
Traders may note the sale for sentiment monitoring, but there is no accompanying fundamental update.
What to watch
The disclosure does not indicate why the sale occurred, and 10b5-1 plans are often used to reduce timing-based inference.
Background
The article is an SEC Form 4 insider transaction for IDEAYA Biosciences, Inc.
Ticker impact
IDEAYA Biosciences CFO Ruiz Briseno Andres sold 9,550 shares for about $382.1K under a pre-arranged 10b5-1 plan.
Likely minimal near-term impact; any effect is more about signaling than fundamentals.
The filing is a Form 4 insider transaction with a stated 10b5-1 plan, and it provides no new company performance, guidance, or regulatory/clinical event.
Market effects
No clear read-across to biotech sector fundamentals from a single planned insider sale.
None indicated.
None indicated.
Counterpoint
Insider selling can still be interpreted as caution, even if 10b5-1, especially if repeated frequently.
Key entities
- issuerIDEAYA Biosciences, Inc.
Company whose CFO insider sale is disclosed on Form 4.
- insiderRuiz Briseno Andres
Chief Accounting Officer who executed the sale under a 10b5-1 plan.
